Xiao-Rong Li Selected Research

Xiao-Rong Li Research Topics

Disease

8	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2024 - 01/2011
8	Neoplasms (Cancer) 09/2023 - 07/2009
6	Cataract (Cataracts) 01/2022 - 01/2011
5	Uveitis 01/2021 - 01/2015
4	Diabetes Mellitus 05/2024 - 07/2012
4	Inflammation (Inflammations) 01/2021 - 01/2016
2	Fibrosis (Cirrhosis) 06/2022 - 09/2011
2	Retinal Perforations 01/2022 - 05/2014
2	Ganglion Cysts (Ganglion) 01/2022 - 01/2015
2	Hypoxia (Hypoxemia) 06/2021 - 02/2018
2	Macular Edema 01/2021 - 05/2018
2	Retinal Neovascularization 01/2020 - 01/2015
2	Pathologic Neovascularization 01/2020 - 10/2019
2	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 01/2012
2	Carcinogenesis 11/2018 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 11/2018 - 01/2014
2	Epiretinal Membrane (Epiretinal Membranes) 10/2015 - 05/2014
2	Cicatrix (Scar) 05/2014 - 01/2011
2	Infarction (Infarctions) 01/2014 - 01/2006
1	Body Weight (Weight, Body) 05/2024
1	Neovascular Glaucoma 04/2024
1	Breast Neoplasms (Breast Cancer) 09/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2023
1	Bites and Stings (Sting) 01/2023
1	Aphakia 01/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Aniridia 01/2023
1	Meibomian Gland Dysfunction 01/2023
1	Aortic Valve Disease 06/2022
1	Ischemia 01/2020
1	Myopia 01/2020
1	Retinal Vein Occlusion 01/2019
1	Altitude Sickness (Mountain Sickness) 02/2018
1	Congenital Nystagmus 01/2018
1	Gliosis 01/2018
1	Strabismus (Squint) 01/2018
1	Amblyopia (Lazy Eye) 01/2018
1	Atrophy 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016
1	Stroke (Strokes) 01/2016

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 01/2022 - 08/2012
5	Therapeutic UsesIBA 01/2023 - 12/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2018 - 01/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 05/2018
3	MicroRNAs (MicroRNA)IBA 01/2014 - 09/2011
3	Messenger RNA (mRNA)IBA 01/2011 - 01/2006
2	rhodiolosideIBA 06/2021 - 02/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 10/2019
2	SteroidsIBA 01/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2012
2	CollagenIBA 10/2015 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2011
1	Blood Glucose (Blood Sugar)IBA 05/2024
1	Glucose (Dextrose)FDA LinkGeneric 05/2024
1	MicrogelsIBA 09/2023
1	poly-N-isopropylacrylamideIBA 09/2023
1	BromidesIBA 09/2023
1	Arachidonic Acid (Vitamin F)IBA 06/2023
1	InterferonsIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	Fenofibrate (CiL)FDA LinkGeneric 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	BerberineIBA 06/2022
1	CalciumIBA 06/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2021
1	Superoxide DismutaseIBA 06/2021
1	Free RadicalsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Mydriatics (Cycloplegics)IBA 01/2020
1	Bromodeoxyuridine (BrdU)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	erucylphosphocholineIBA 10/2019
1	Activating Transcription Factor 2IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	ForminsIBA 11/2018
1	Tight Junction ProteinsIBA 02/2018
1	EnzymesIBA 02/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018
1	afliberceptIBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	RC28-E proteinIBA 01/2018
1	CytokinesIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 12/2015
1	Beclin-1IBA 12/2015

Therapy/Procedure

5	Vitrectomy 04/2024 - 01/2011
5	Therapeutics 06/2022 - 06/2009
3	Lasers (Laser) 09/2023 - 01/2013
2	Phacoemulsification 01/2022 - 01/2021
1	Sutures (Suture) 01/2023
1	Intraocular Lens Implantation 01/2021
1	Oral Medicine 01/2021
1	Intravitreal Injections 03/2020
1	Injections 01/2020
1	Refractive Surgical Procedures 01/2018
1	Treatment Delay 01/2016